The FDA requires animal testing for most chemical sunscreen ingredients because they absorb into the bloodstream, and current science cannot predict safety risks without animal studies. Following 2019 research showing systemic absorption of certain UV filters, the Food and Drug Administration (FDA) has mandated enhanced testing on 14 chemical sunscreen ingredients, while only two mineral alternatives remain exempt from this requirement.

Which Sunscreen Ingredients Require Animal Testing?

The FDA's animal testing mandate covers a long list of chemical UV filters commonly found in sunscreens. These ingredients are required to undergo animal studies because they penetrate the skin and enter the bloodstream, raising questions about long-term safety that regulators say cannot be answered through alternative methods.

• Aminobenzoic acid (PABA): One of the oldest UV filters, now less common but still regulated
• Oxybenzone: A widely used chemical filter that absorbs readily into skin
• Octinoxate: A UVB filter found in many commercial sunscreens
• Homosalate: A chemical filter that enhances absorption of other ingredients
• Avobenzone: A UVA filter used in broad-spectrum formulas
• Octocrylene: A photostabilizer that prevents UV filter breakdown
• Ensulizole, cinoxate, dioxybenzone, meradimate, octisalate, padimate O, sulisobenzone, and trolamine salicylate: Additional chemical filters subject to testing requirements

In contrast, only two ingredients have been cleared from enhanced animal testing: zinc oxide and titanium dioxide, both mineral-based UV blockers that sit on top of the skin rather than absorbing into it.

Why Can't the FDA Use Non-Animal Testing Methods?

When asked about the legitimacy of relying on animal studies in an interview with BeautyMatter, an FDA official explained the regulatory position plainly. The agency maintains that current science simply does not offer a reliable alternative for predicting how absorbed chemicals might affect human health over time.

"The FDA routinely evaluates drugs that are absorbed into the body to ensure that the benefits of these products outweigh any potential risks that result from absorption. While many drugs do not show risks from systemic exposure, it is not possible to predict these potential risks under any scientifically valid and reliable method at this time aside from animal studies," stated an FDA representative.

FDA Official, U.S. Food and Drug Administration

This stance reflects a fundamental challenge in toxicology: without animal models, regulators cannot reliably test how a chemical behaves when it enters the bloodstream, how it accumulates in organs, or what effects it might have on hormones, reproduction, or long-term health. The FDA argues that the absorption data from 2019 raised enough safety questions to justify the additional testing burden.

How Are Ingredient Suppliers and Brands Responding?

The animal testing requirement has had a significant ripple effect across the sunscreen industry. Major ingredient suppliers and brands have begun withdrawing from the U.S. market rather than invest in costly animal studies. BASF Care Chemicals, a German-headquartered supplier that has spent decades developing and advocating for animal-free testing methods, has been among those reconsidering their U.S. presence.

This regulatory barrier has reduced the diversity of sunscreen options available to American consumers. Brands that rely on chemical filters developed in Europe or other regions often cannot afford or are unwilling to conduct animal testing to gain FDA approval for U.S. sale. The result is a narrower market with fewer innovative formulations reaching consumers.

What About Newer Chemical Filters Like Bemotrizinol?

The FDA has been reviewing bemotrizinol, a newer broad-spectrum chemical filter marketed under the brand name PARSOL Shield, for potential approval in the United States. This ingredient is lighter and less greasy than many traditional chemical alternatives, and it has already been approved and used in sunscreens sold by brands like La Roche Posay, Ultra Violette, and Reimann P20 in other countries.

A decision on bemotrizinol's U.S. approval status was expected by March 2026, though the regulatory timeline for new chemical UV filters remains lengthy due to the animal testing requirements.

How Does This Compare to Regulations in Other Countries?

The U.S. approach stands in contrast to regulatory frameworks in other regions. In the United Kingdom, animal testing is not mandatory for sunscreen ingredients; as of 2023, the government ensured that no new licenses will be granted for animal testing of cosmetics. This difference means that consumers in the UK and EU may have access to a broader range of chemical sunscreen options than those available in the United States.

The regulatory divide reflects a broader tension in the beauty and personal care industry: how to balance consumer access to innovative products with concerns about ingredient safety and ethical testing practices. For now, the FDA's position remains that animal studies are the only scientifically valid way to assess the safety of sunscreen ingredients that absorb into the bloodstream.